Cas9-AAV6-engineered human mesenchymal stromal cells improved cutaneous wound healing in diabetic mice
Human mesenchymal stromal cells are a promising source for cell-based therapies. Here the authors use Cas9 to engineer lines that secrete PDGF-BB and VEFGA for improving wound healing.
Guardado en:
Autores principales: | Waracharee Srifa, Nina Kosaric, Alvaro Amorin, Othmane Jadi, Yujin Park, Sruthi Mantri, Joab Camarena, Geoffrey C. Gurtner, Matthew Porteus |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f1e0b2e3490d49f9b4d885258b1c4088 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Editorial: Inflammation in Healing and Regeneration of Cutaneous Wounds
por: Allison J. Cowin, et al.
Publicado: (2021) -
Cas9-AAV6 gene correction of beta-globin in autologous HSCs improves sickle cell disease erythropoiesis in mice
por: Adam C. Wilkinson, et al.
Publicado: (2021) -
An Overview of Cutaneous Wounds and the Beneficial Roles of Medicinal Plants in Promoting Wound Healing
por: Nura Muhammad Umar, et al.
Publicado: (2021) -
Keratinocyte-targeted overexpression of the glucocorticoid receptor delays cutaneous wound healing.
por: Ana Sanchis, et al.
Publicado: (2012) -
Healing of cutaneous wounds using GaAs laser in diabetic rat models
por: P. Nekha Krishnan, et al.
Publicado: (2021)